15:00 ETBioOra and Cincinnati Children's Hospital Medical Center Partner to Advance Next-Generation CAR-T Therapy for Children with Leukaemiaprnewswire·Apr 13 at 07:00 PMBIORQ0.00%BIOR0.00%
AI HealthTech Biorce Opens U.S. Offices in Austin to Accelerate Global Expansionbiopharmadive·Apr 7 at 02:23 PMBIOR0.00%
BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platformbiopharmadive·Apr 7 at 02:18 PMBIB+4.51%BIOR0.00%
UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION | BORAY Stock NewsStockTitan·Apr 6 at 10:05 AMBMRN+0.54%BBH+2.40%
09:47 ETBioretec Ltd publishes an exemption document relating to its rights issueprnewswire·Apr 2 at 01:49 PMBIOR0.00%
08:50 ETInside information: Bioretec Ltd's Board of Directors resolved on a rights issue of up to approximately EUR 14.8 million and publishes the terms and conditions of the rights issueprnewswire·Mar 27 at 12:52 PMBIORQ0.00%BIOR0.00%
12:07 ETBioretec Ltd's Financial Statements and Annual Report 2025 publishedprnewswire·Mar 13 at 04:08 PMBIORQ0.00%BIOR0.00%
12:08 ETInside information: Timo Lehtonen takes on a new role at Bioretec as External Executive Advisor and steps down from the management teamprnewswire·Mar 12 at 04:10 PMXBI+2.64%PBE+2.46%
16:13 ETNotice of the Extraordinary General Meeting of Bioretec Ltdprnewswire·Mar 10 at 08:13 PMBIOR0.00%BIORQ0.00%
Bioretec Ltd's financials for Jan-Dec 2025: Net sales EUR 3,522k (-22.5% vs 2024), EBITDA EUR -8,476k. Strategy update for 2026–2028.Unusual Whales·Feb 13 at 08:07 AMBIOR0.00%BIORQ0.00%
Biotalys and 21st.BIO partner to advance biocontrol production; Biotalys updates funding plans for next phase of development.Unusual Whales·Jan 23 at 06:01 AMBIB+4.51%PBE+2.46%
